Activity of amoxicillin, metronidazole, bismuth salicylate and six aminoglycosides against Helicobacter pylori

Journal of Chemotherapy

Volumn 8, Issue 1, 1996, Pages 52-54

  Brenciaglia, M I ^a   Fornara, A M ^a   Scaltrito, M M ^a   Braga, P C ^a   Dubini, F ^a  

^a Istituto di Microbiologia Medica   (Italy)

Author keywords

Aminoglycosides; Amoxicillin; Bismuth salicylate; Helicobacter pylori; Metronidazole; Susceptibility

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; BISMUTH SALICYLATE; GENTAMICIN; METRONIDAZOLE; NETILMICIN; RIBOSTAMYCIN; STREPTOMYCIN; TOBRAMYCIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; HELICOBACTER PYLORI; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN;

EID: 0030050395     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.1996.8.1.52     Document Type: Article

References (13)

1. Lee A, Fox J, Hazell S. Pathogenicity of Helicobacter pylori: a perspective. Infect Immun 1993; 61: 1601-10.
2. Sipponen P, Hyvarinen H. Role of Helicobacter pylori in the pathogenesis of gastritis, peptic ulcer and gastric cancer. Scand J Gastroenterol 1993; Suppl.196: 3-6.
3. Bell GD, Powell KV. Eradication of Helicobacter pylori and its effect in peptic ulcer disease. Scand J Gastroenterol 1993; Suppl.196: 7-11.
4. Bell GD, Weil J, Powell K, et al. Helicobacter pylori treated with combinations of tripotassium dicitrate and metronidazole: efficacy of different treatment regimens and some observations on the emergence of metronidazole resistance. Eur J Gastroenterol Hepatol 1991; 3: 819-22.
5. Becx MCJM, Janssen AJHM, Clasener HAL, De Koning RW. Metronidazole resistant Helicobacter pylori. Lancet 1990; 335: 539-40.
6. Rautelin H, Seppalla K, Renkonen OV, Vainio U, Kosunen TU. Role of metronidazole resistance in therapy of Helicobacter pylori infections. Antimicrob Agents Chemother 1992; 36: 163-66.
7. Van Zwet AA, Thijs JC, Schievink-De Vries W, Schiphuis J, Snijder JA. In vitro studies on stability and development of metronidazole resistance in Helicobacter pylori. Antimicrob Agents Chemother 1994; 38: 360-62.
8. Simor AE, Ferro S, Low DE. Comparative in vitro activities of six new fluoroquinolones and other oral antimicrobial agents against Campylobacter pylori. Antimicrob Agents Chemother 1989; 33:108-09.
9. Goodwin CS, Marshall BJ, Blincow ED, Wilson DH, Blackbourn S, Phillips M. Prevention of nitroimidazole resistance in Campylobacter pylori infections by coadministration of colloidal bismuth subcitrate: clinical and in vitro studies. J Clin Pathol 1988; 41: 207-10.
10. Morgan D, Kraft W, Bender M, Pearson A. Nitrofurans in the treatment of gastritis associated with Campylobacter pylori. Gastroenterology 1988; 95: 1178-84.
11. Glupczynski Y, Burette. A. Failure of azithromycin to eradicate Campylobacter pylori from the stomach because of acquired resistance during treatment. Am J Gastrenterol 1990; 85: 98-99.
12. NCCLS. Methods for antimicrobial susceptibility tests of anaerobic bacteria. 2nd Ed. vol.9 n°10. Approved Standard M11-A2 National Committee for Clinical Laboratory Standards - Villanova, Pa, 1990.
13. Gudmundsson A, Erlendsdottir H, Gottfredsson M, Gudmundsson S. Impact of pH and cationic supplementation on in vitro postantibiotic effect. Antimicrob Agents Chemother 1991; 35:2617-2624.